Estadístiques de Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer
Visites totals
| views | |
|---|---|
| Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer | 74 |
Visites totals per mes
| views | |
|---|---|
| September 2024 | 9 |
| October 2024 | 0 |
| November 2024 | 6 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Solomon_fo_phas.pdf(legacy) | 56 |
| Solomon_fo_phas.pdf | 19 |
Vistes principals per país
| views | |
|---|---|
| United States | 51 |
| Iran | 6 |
| Australia | 4 |
| Belgium | 4 |
| Spain | 3 |
| China | 2 |
| Argentina | 1 |
| Germany | 1 |
| India | 1 |
| Philippines | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 22 |
| Fairfield | 4 |
| Mountain View | 4 |
| Menlo Park | 3 |
| Sacramento | 3 |
| Ann Arbor | 2 |
| Barcelona | 2 |
| Boardman | 2 |
| Little Falls | 2 |
| Almería | 1 |
| Ashburn | 1 |
| Durham | 1 |
| Lexington | 1 |
| Pinjarra | 1 |
| Redwood City | 1 |
| Rochester | 1 |
| San Diego | 1 |
| Somerville | 1 |
| Suipacha | 1 |
| Thane | 1 |